Results 111 to 120 of about 29,315 (207)

Disproportionality analysis of fondaparinux associated adverse events based on the FDA adverse event reporting system. [PDF]

PLoS One
Kang F, Wang Y, Cai F, Wu L, Han L, Yin Q, Bian Y.   +6 more
europepmc   +1 more source

Adverse event profile of fondaparinux sodium: a disproportionality analysis based on FAERS, JADER, and VigiAccess databases. [PDF]

Front Med (Lausanne)
Jin W, Pan J, Yu L, Zhu M.
europepmc   +1 more source

Safety Profile and Bleeding Complications of Fondaparinux Versus Enoxaparin in Non-ST Elevation Acute Coronary Syndrome. [PDF]

Cureus
Rahman MM, Ahmed FU, Chowdhury MI, Noor H, Hossain MA.   +4 more
europepmc   +1 more source

Safety of Fondaparinux After Low-Molecular-Weight Heparin in Bleeding-Complicated High-Risk Pregnancies: A PSM Cohort Study. [PDF]

Int J Womens Health
Yang H, Gao Y, Song X.
europepmc   +1 more source

Fondaparinux [PDF]

, 2019
openaire   +1 more source

Radial Access and Fondaparinux: A Synergistic Interaction. [PDF]

Arq Bras Cardiol
Andrade PB, Silva LMA.
europepmc   +1 more source

The Necessity to Provide an Informed Choice Regarding Venous Thromboembolism Prophylaxis: A Single-Centre Study Observing Clinician Adherence and Opinions on Venous Thromboembolism Prophylaxis. [PDF]

Cureus
Patel U, Siddiqui IRA, Lodi A, Ziade G, Aziz I.   +4 more
europepmc   +1 more source

Long-term anticoagulation with fondaparinux in a patient with a mechanical heart valve [PDF]

, 2018
Haslauer, Michael, Nagler, Michael, Wuillemin, Walter   +2 more
core  

Autoimmune heparin-induced thrombocytopenia following cardiac surgery. [PDF]

BMJ Case Rep
St Bernard R, Nazy I, Warkentin TE.
europepmc   +1 more source

Current Trends in Venous Thromboprophylaxis for Inpatient Care. [PDF]

J Pers Med
Velliou M, Bistola V, Parissis J, Polyzogopoulou E.   +3 more
europepmc   +1 more source